Why the study?
Does stanozolol affect blood coagulation and fibrinolysis in normal subjects?
Does stanozolol affect blood coagulation and fibrinolysis in normal subjects?
Stanozolol administration at 5 mg twice daily for six weeks significantly stimulates the fibrinolytic system and reduces fibrinogen levels in normal volunteers.
Stanozolol may enhance fibrinolysis in healthy subjects; hypothesis-generating for antithrombotic applications pending controlled trials.
In a volunteer study stanozolol was given in a dosage of 5mg twice per day for six weeks. A variety of parameters in blood coagulation and fibrinolysis were measured. Significant stimulation of the fibrinolytic system was found in seven days and this was associated with a significant fall in the levels of fibrinogen and alpha 2-macroglobulin. No major side effects were observed.
No takes yet. Share an insight, caveat, or question.
F E Preston (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: